Prospects for active immunotherapies for hepatitis B virus chronic carriers.
Michel
M L
ML
Unité de Recombinaison et Expression Génétique, INSERM U 163, Institut Pasteur, Paris.
D000256:Adenoviridae / Q000235:genetics; D002353:Carrier State; D015316:Genetic Therapy; D005822:Genetic Vectors; D006509:Hepatitis B / Q000276:immunology / Q000628:therapy*; D017325:Hepatitis B Vaccines / Q000627:therapeutic use; D006801:Humans; D016233:Immunotherapy, Active; D012190:Retroviridae / Q000235:genetics
D017325:Hepatitis B Vaccines